Literature DB >> 11028115

Guillian Barré syndrome--recent advances.

V V Vedanarayanan1, V Chaudhry.   

Abstract

Guillian Barré Syndrome (GBS) is an acquired disease of the peripheral nerves that is characterized clinically by rapidly progressing paralysis, areflexia, and albumino-cytological dissociation. It affects both genders, involves people of all ages, is reported worldwide, and in the post-polio era, it is the most common cause of an acute generalized paralysis. The clinical features are distinct and a history and an examination generally lead to a high suspicion of the diagnosis that can then be confirmed by supportive laboratory tests and electrodiagnostic studies. This review discusses the recent advances in understanding of the different variants of GBS such as acute inflammatory demyelinating polyneuropathy (AIDP), acute motor axonal neuropathy (AMAN), acute motor sensory axonal neuropathy (AMSAN), and the Fisher syndrome. The clinical, electrodiagnostic criteria, immunopathogenesis, and management of GBS and its variants are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11028115     DOI: 10.1007/BF02762173

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   5.319


  64 in total

1.  An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia).

Authors:  M FISHER
Journal:  N Engl J Med       Date:  1956-07-12       Impact factor: 91.245

2.  A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.

Authors:  F G van der Meché; P I Schmitz
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

3.  Patterns of recovery in the Guillain-Barre syndromes.

Authors:  T W Ho; C Y Li; D R Cornblath; C Y Gao; A K Asbury; J W Griffin; G M McKhann
Journal:  Neurology       Date:  1997-03       Impact factor: 9.910

4.  Transfer of experimental allergic neuritis with P2-reactive T-cell lines.

Authors:  A Rostami; J B Burns; M J Brown; J Rosen; B Zweiman; R P Lisak; D E Pleasure
Journal:  Cell Immunol       Date:  1985-04-01       Impact factor: 4.868

5.  Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis.

Authors:  G M McKhann; J W Griffin; D R Cornblath; E D Mellits; R S Fisher; S A Quaskey
Journal:  Ann Neurol       Date:  1988-04       Impact factor: 10.422

6.  Criteria for diagnosis of Guillain-Barré syndrome.

Authors: 
Journal:  Ann Neurol       Date:  1978-06       Impact factor: 10.422

7.  Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection.

Authors:  D R Cornblath; J C McArthur; P G Kennedy; A S Witte; J W Griffin
Journal:  Ann Neurol       Date:  1987-01       Impact factor: 10.422

8.  A prospective clinical and electrophysiologic survey of acute flaccid paralysis in Chinese children.

Authors:  H S Wu; T C Liu; Z L Lü; L P Zou; W C Zhang; G Zhaori; J Zhang
Journal:  Neurology       Date:  1997-12       Impact factor: 9.910

9.  Conduction block and denervation in Guillain-Barré polyneuropathy.

Authors:  W F Brown; T E Feasby
Journal:  Brain       Date:  1984-03       Impact factor: 13.501

10.  Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies.

Authors:  A Chiba; S Kusunoki; H Obata; R Machinami; I Kanazawa
Journal:  Neurology       Date:  1993-10       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.